Clinical outcome following the use of inadequate solutions for continuous veno-venous hemodiofiltration

Renal Failure

Volumn 30, Issue 10, 2008, Pages 959-964

  Celik, Jale Bengi ^a   Topal, Ahmet ^a   Kartal, Elmas ^a   Yosunkaya, Alper ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Continuous renal replacement therapy; Dialysate; Metabolic disturbances

Indexed keywords

BICARBONATE; DIALYSIS FLUID; GLUCOSE; LACTIC ACID; PERITONEAL DIALYSIS FLUID; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; DEMOGRAPHY; DIALYSATE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOFILTRATION; HUMAN; HYPERGLYCEMIA; HYPOTENSION; LABORATORY TEST; LACTATE BLOOD LEVEL; MALE; MEDICAL RECORD REVIEW; METABOLIC ACIDOSIS; METABOLIC DISORDER; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ACIDOSIS; AGED; DIALYSIS SOLUTIONS; FEMALE; HEMODIAFILTRATION; HUMANS; HYPERGLYCEMIA; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 57049104698     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802422028     Document Type: Article

References (20)

1. Berger MM, Shenkin A, Revelly JP, Roberts E, Cayeux MC, Baines M, Chiolero RL. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr. 2004;80:410-416.
2. Soysal DD, Karaböcüoǧlu M, Çitak A, Üçsel R, Uzel N, Nayir A. Metabolic distrubances following the use of inadequate solutions for hemofiltration in acute renal failure. Pediatr Nephrol. 2007;22:715-719.
3. Bollmann MD, Revelly JP, Tappy L, Berger MM, Schaller MD, Cayeux MC, Martinez A, Chiolero RL. Effect of bicarbonate and lactate metabolism during hemodiafiltration in patients with multiple organ failure. Intensive Care Med. 2004;30:1103-1110.
4. Barenbrock M, Hausberg M, Matzkies F, Motte S, Schaeffer R M. Effects of bicarbonate-and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int. 2000;58:1751-1757.
5. Williams DM, Sreedhar SS, Mickell JJ, Chan JC. Acute kidney failure: A pediatric experience over 20 years. Arch Pediatr Adolesc Med. 2002;156:893-900.
6. Odetola F, Bratton S, Clark S, Davis M. Availability of advanced therapeutic modalities in U.S. pediatric intensive care units, 2004. Crit Care Med. 2004;32 (Suppl.):A86.
7. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan C, Harman EM, Henderson GN, Jenkinson S, Lachin JM, Lorenz A, Schneider SH, Siegel JH, Summer WR, Thompson D, Wolfe CL, Zorovich B. Natural history and course of acquired lactic acidosis in adults. Am J Med. 1994;97:47-54.
8. Davenport A, Will EJ, Davison AM. Hyperlactatemia and metabolic acidosis during haemofiltration using lactate-buffered fluids. Nephron. 1991;59:461-465.
9. McLean AG, Davenport A, Cox D, Sweny P. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction. Kidney Int. 2000;58: 1765-1772.
10. Schetz M, Leblanc M, Murray PT. The acute dialysis quality initiative, part VII: Fluid composition and management in CRRT. Adv Ren Replace Ther. 2002;9:282-289.
11. Zimmerman D, Cotman P, Ting P, Karanicolas S, Tobe SW. Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buggered solution. Nephrol Dial Transplant. 1999;14:2387-2391.
12. Reynolds HN, Borg U, Belzberg H, Wiles CE. Efficacy of continuous arteriovenous hemofiltration with dialysis in patients with renal failure. Crit Care Med. 1991;19:1387-1394.
13. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Boullon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
14. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med. 2004;5:329-336.
15. Tappy L, Chiolero R, Berger M. Autoregulation of glucose production in health and disease. Curr Opin Clin Nutr Metab Care. 1999;2:161-164.
16. Tappy L, Cayeux MC, Schneiter P, Schindler C, Temler E, Jequier E, Chiolero R. Effects of lactate on glucose metabolism in healthy subjects and in severely injured hyperglycemic patients. Am J Physiol. 1995;268:E630-E635.
17. Himmelfarb J. Dialytic therapy in acute renal failure: No reason for nihilism. Semin Dial. 1996;9:230-234.
18. Davenport A, Will E, Davison AM. The effect of lactate-buffered solutions on the acid-base status of patients with renal failure. Nephrol Dial Transplant. 1989;4:800-804.
19. Thomas AN, Guy JM, Kishen R, Geraghty IF, Bowles BJ, Vadgama P. Comparison of lactate and bicarbonate buffered haemofiltration fluids: Use in critically ill patients. Nephrol Dial Transplant. 1997;12:1212-1217.
20. Heereing P, Ivens K, Thürmer O, Morgera O, Heintzen M, Passlick-Deetjen J, Willers R, Strauer BE, Grabensee B. The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intensive Care Med. 1999;25:1244-1251.